<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR63">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Leussink</surname>
    <given-names>VI</given-names>
   </name>
   <name>
    <surname>Husseini</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Warnke</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Broussalis</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Hartung</surname>
    <given-names>HP</given-names>
   </name>
   <name>
    <surname>Kieseier</surname>
    <given-names>BC</given-names>
   </name>
  </person-group>
  <article-title>Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity</article-title>
  <source>Therapeutic Adv Neurol Disord</source>
  <year>2012</year>
  <volume>5</volume>
  <issue>5</issue>
  <fpage>255</fpage>
  <lpage>266</lpage>
  <pub-id pub-id-type="doi">10.1177/1756285612453972</pub-id>
 </element-citation>
</ref>
